+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group



A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group



New England Journal of Medicine 326(9): 581-588



The use of corticosteroids to treat optic neuritis is controversial. At 15 clinical centers, we randomly assigned 457 patients with acute optic neuritis to receive oral prednisone (1 mg per kilogram of body weight per day) for 14 days; intravenous methylprednisolone (1 g per day) for 3 days, followed by oral prednisone (1 mg per kilogram per day) for 11 days; or oral placebo for 14 days. Visual function was assessed over a six-month follow-up period. Visual function recovered faster in the group receiving intravenous methylprednisolone than in the placebo group; this was particularly true for the reversal of visual-field defects (P = 0.0001). Although the differences between the groups decreased with time, at six months the group that received intravenous methylprednisolone still had slightly better visual fields (P = 0.054), contrast sensitivity (P = 0.026), and color vision (P = 0.033) but not better visual acuity (P = 0.66). The outcome in the oral-prednisone group did not differ from that in the placebo group. In addition, the rate of new episodes of optic neuritis in either eye was higher in the group receiving oral prednisone, but not the group receiving intravenous methylprednisolone, than in the placebo group (relative risk for oral prednisone vs. placebo, 1.79; 95 percent confidence interval, 1.08 to 2.95). Intravenous methylprednisolone followed by oral prednisone speeds the recovery of visual loss due to optic neuritis and results in slightly better vision at six months. Oral prednisone alone, as prescribed in this study, is an ineffective treatment and increases the risk of new episodes of optic neuritis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039105607

Download citation: RISBibTeXText

PMID: 1734247

DOI: 10.1056/nejm199202273260901


Related references

The SKILL Card test in optic neuritis: experience of the Optic Neuritis Treatment Trial. Smith-Kettlewell Institute Low Luminance. Optic Neuritis Study Group. Journal of Neuro-Ophthalmology 21(2): 124-131, 2001

Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Archives of Ophthalmology 111(2): 231-234, 1993

Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group. Archives of Ophthalmology 115(12): 1545-1552, 1997

The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Archives of Ophthalmology 109(12): 1673-1678, 1991

Incidence of acute idiopathic optic neuritis and its therapy in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Nippon Ganka Gakkai Zasshi 99(1): 93-97, 1995

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. New England Journal of Medicine 329(24): 1764-1769, 1993

Visual field reading center optic neuritis treatment trial the optic neuritis study group. Investigative Ophthalmology & Visual Science 31(4 ABSTR ISSUE): 609, 1990

The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group. Journal of Neuro-Ophthalmology 15(3): 131-135, 1995

The optic neuritis treatment trial. Implications for clinical practice. Optic Neuritis Study Group. Archives of Ophthalmology 110(3): 331-332, 1992

Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial. JAMA Ophthalmology 132(4): 421-427, 2014

Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial. Ophthalmology 100(5): 691-7; Discussion 697-8, 1993

Cerebrospinal fluid in acute optic neuritis: Experience of the optic neuritis treatment trial. Neurology 46(2): 368-372, 1996

Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Japanese Journal of Ophthalmology 43(2): 133-138, 1999

Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Japanese Journal of Ophthalmology 43(2): 127-132, 1999

Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group. Archives of Neurology 50(8): 841-846, 1993